SONOMA PHARMACEUTICALS, INC. Deferred Federal Income Tax Expense (Benefit)
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-21.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2023-06-21
- SONOMA PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2023 was $0.00.
- SONOMA PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2022 was $0.00.
- SONOMA PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2021 was $0.00.
- SONOMA PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2020 was $0.00.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2023-03-31 | $0.00 10-K · filed 2023-06-21 |
| 2022-03-31 | $0.00 10-K · filed 2023-06-21 |
| 2021-03-31 | $0.00 10-K · filed 2022-07-13 |
| 2020-03-31 | $0.00 10-K · filed 2021-07-14 |
| 2019-03-31 | $0.00 10-K · filed 2020-07-10 |
| 2018-03-31 | $0.00 10-K · filed 2019-07-01 |
| 2017-03-31 | -$3.27M 10-K · filed 2018-06-26 |
| 2016-03-31 | $0.00 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |